Topical tacrolimus (FK 506): A new milestone in the management of atopic dermatitis
Author:
- Thomas BieberTBThomas Bieber
- 1 October 1998
- journal article
- editorial
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 102 (4) , 555-557
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in childrenJournal of Allergy and Clinical Immunology, 1998
- Tacrolimus Ointment does not Affect Collagen Synthesis: Results of a Single-Center Randomized TrialJournal of Investigative Dermatology, 1998
- A Short-Term Trial of Tacrolimus Ointment for Atopic DermatitisNew England Journal of Medicine, 1997
- FcεRI-expressing antigen-presenting cells: new players in the atopic gameImmunology Today, 1997
- Systemic Tacrolimus (FK 506) Is Effective for the Treatment of Psoriasis in a Double-blind, Placebo-Controlled StudyArchives of Dermatology, 1996
- Tacrolimus ointment for atopic dermatitisThe Lancet, 1994
- The skin immune system: progress in cutaneous biologyImmunology Today, 1993
- Anti-Inflammatory Effect of FK-506 on Human Skin Mast CellsJournal of Investigative Dermatology, 1992
- Inhibition of contact allergy reactions by topical FK506The Lancet, 1992
- The mechanism of action of cyclosporin A and FK506Immunology Today, 1992